Genetic Characteristics of HER2 Positive Breast Cancer With Neoadjuvant TCHP Chemotherapy
Status: UNKNOWN
Study type: OBSERVATIONAL
Conditions: HER2-positive Breast Cancer|Chemotherapy Effect|Circulating Tumor DNA
Interventions: DIAGNOSTIC_TEST: LiquidSCAN(Trade Mark) / CancerSCAN(Trade Mark)
Sponsor: Samsung Medical Center